Design Therapeutics Inc. (DSGN)
4.14
0.12 (2.99%)
At close: Jan 15, 2025, 11:51 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -66.86M | -63.31M | -35.53M | -8.28M | -2.05M |
| Depreciation & Amortization | 537.00K | 406.00K | 129.00K | 5.00K | n/a |
| Stock-Based Compensation | 13.09M | 10.93M | 4.69M | 450.00K | n/a |
| Other Working Capital | 1.97M | -3.39M | -1.02M | -398.00K | 1.81M |
| Other Non-Cash Items | -6.05M | -1.33M | 19.00K | 38.00K | 95.00K |
| Deferred Income Tax | n/a | n/a | -77.00K | -71.00K | n/a |
| Change in Working Capital | 728.00K | 1.99M | 1.40M | -811.00K | 1.81M |
| Operating Cash Flow | -58.56M | -51.32M | -29.38M | -8.67M | -139.00K |
| Capital Expenditures | -256.00K | -918.00K | -1.54M | -76.00K | n/a |
| Acquisitions | n/a | 39.00K | 52.11K | 33.48K | n/a |
| Purchase of Investments | -224.70M | -313.00M | -86.26M | -55.59M | n/a |
| Sales Maturities Of Investments | 277.50M | 92.89M | 34.16M | 22.10M | n/a |
| Other Investing Acitivies | n/a | 39.00K | -52.11K | -33.48K | n/a |
| Investing Cash Flow | 52.54M | -220.99M | -53.64M | -33.56M | n/a |
| Debt Repayment | n/a | n/a | n/a | 44.53M | 196.00K |
| Common Stock Repurchased | 305.00K | 339.00K | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 724.00K | 235.00K | 124.94M | 1K | n/a |
| Financial Cash Flow | 724.00K | 235.00 | 379.21K | 44.53M | 196.00K |
| Net Cash Flow | -5.30M | -272.07M | 296.19M | 2.30M | 57.00K |
| Free Cash Flow | -58.82M | -52.23M | -30.91M | -8.74M | -139.00K |